4//SEC Filing
Jaffe Matthias 4
Accession 0001209191-20-024993
CIK 0001664106other
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 8:00 PM ET
Size
5.8 KB
Accession
0001209191-20-024993
Insider Transaction Report
Form 4
Jaffe Matthias
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2020-04-15+17,218→ 17,218 total→ Common Stock (17,218 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of LogicBio Therapeutics Inc. (the "Company") common stock.
- [F2]The RSUs will fully vest on April 15, 2021, subject to the terms and conditions of the award and the Company's 2018 Equity Incentive Plan; provided, that if the reporting person's employment is terminated by the Company without "cause" or by the reporting person for "good reason" (as defined in the reporting person's employment agreement) prior to April 15, 2021, all such RSUs will vest on the date of termination.
Documents
Issuer
LogicBio Therapeutics, Inc.
CIK 0001664106
Entity typeother
Related Parties
1- filerCIK 0001752457
Filing Metadata
- Form type
- 4
- Filed
- Apr 16, 8:00 PM ET
- Accepted
- Apr 17, 8:00 PM ET
- Size
- 5.8 KB